Form 4 for NTLA Intellia Therapeutics, Inc.
Accepted 2023-01-06 00:00:00 ET · period of report 2023-01-04 · accession 0001209191-23-002425 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-01-06 | 2023-01-04 | NTLA | LEONARD JOHN M | Pres, CEO, Dir | S - Sale | $37.21 | -6,673 | 766.8K | -0.9% | -$248.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-04 | S | D | 6,673 | $37.21 | 766,825 | D | — | — | (F1) Shares sold in sell-to-cover transaction in order to satisfy withholding taxes to be paid upon the vesting of RSUs on January 1, 2023. |